Analysed INFLARX NV (IFRX:NASDAQ) News Sources
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
09-04-2026
yahoo.com
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
04-05-2026
yahoo.com
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
06-05-2026
yahoo.com
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
06-05-2026
yahoo.com
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
08-05-2026
yahoo.com
What is the current price of INFLARX NV (IFRX:NASDAQ)?
The current price of INFLARX NV (IFRX:NASDAQ) is $2.56.
INFLARX NV (IFRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of INFLARX NV (IFRX:NASDAQ) since the previous trading day is $-0.18.
INFLARX NV (IFRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of INFLARX NV (IFRX:NASDAQ) since the previous trading day is -6.5693%.
What is the most recent average sentiment score for INFLARX NV (IFRX:NASDAQ)?
The most recent average sentiment score for INFLARX NV (IFRX:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for INFLARX NV (IFRX:NASDAQ)?
The most recent sentiment for INFLARX NV (IFRX:NASDAQ) is .
SEC-8K** Filing Available For INFLARX NV (IFRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.